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  ABSTRACT 
Paula Muñoz 
Impact of Positive Diet and Physical Activity Behaviors on the Effectiveness of the Influenza 
Vaccine in Obese Adults 
(Under the direction of Dianne Ward, Ed.D and Melinda Beck, Ph.D) 
 
 
Obesity is a public health epidemic that is associated with increased risk of developing a 
large number of negative health implications, including being linked with increased 
susceptibility to viral infections. Influenza is an acute viral infection that affects the respiratory 
systems and is caused by the influenza virus. Every year, influenza infects a large portion of the 
population and can even result in death. During the H1N1 2009 pandemic, obesity was identified 
as an independent risk factor for the influenza virus. Vaccination has been identified as the most 
effective method for prevention of the virus, however obese adults have shown impaired 
immunological response to influenza vaccination. Increased physical activity and consumption 
of high quality diets have been shown to produce increased immune response, however the 
impact that these lifestyle factors have on obese adults receiving the influenza vaccine is 
unknown. 
The purpose of this study was to determine the effects that positive diet and physical 
activity behaviors had on the effectiveness of the influenza vaccine in obese adults. A sample of 
40 subjects were selected and classified into two groups by lifestyle category, healthy and 
unhealthy, through the use of a diet and physical activity survey screener. Blood serum was 
collected pre- and 30 days post-vaccination, and IgG antibody levels were measured through 
absorbance readings.  
Although there were no statistically significant differences in the percent change in IgG  
ii 
	  levels between the unhealthy and healthy groups, the larger percent change exhibited by obese 
adults classified as healthy, and among those with higher physical activity levels and better diet 
quality scores, suggests a better response to the influenza virus compared to the obese 
participants who were unhealthy, with lower physical activity levels and low quality diets. 
Therefore, obese adults who follow healthy lifestyles may be better protected from the influenza 
virus than obese adults who do not. As the prevalence of obesity among the population continues 
to increase, it will be important to find ways to increase the effectiveness of the flu vaccine 
among this vulnerable population in order to reduce the morbidity and mortality which 
accompanies the influenza virus.  
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  CHAPTER 1 
INTRODUCTION, AIMS, AND HYPOTHESIS 
 
The World Health Organization (WHO) concluded in a recent report that being 
overweight or obese was the fifth primary risk factor for death around the world (WHO 2013). 
For adults, overweight and obese status is defined through the calculation of a body mass index 
(BMI), which takes into account the weight and height of the individual (CDC 2012). An adult 
who is considered overweight has a BMI that falls between 25 and 29.9 kg/m2. An adult who is 
categorized as obese has a BMI that is 30 kg/m2 or higher (CDC 2012). Obesity has been further 
categorized into more specific stages including stage I (mild) with a BMI between 30 to 34.9, 
stage II (moderate) with a BMI between 35 to 39.9, and stage III (severe) with a BMI greater 
than or equal to 40 kg/m2 (Cornier et al. 2011). It is estimated that 2.8 million people die each 
year from obesity and overweight-related illnesses (WHO 2013). Individuals who are overweight 
and obese have been found to have increased associations with all-cause mortality when 
compared to those who are normal weight (Berrington de Gonzales et al. 2010). Having a higher 
BMI has been linked with higher instances of developing negative health conditions such as 
coronary heart disease, heart attacks, and strokes (Owen et al. 2009, Song et al. 2009). Since 
1980, the worldwide population of obese individuals has almost doubled leading to an estimate 
of 500 million adults worldwide being classified as obese (WHO 2013). It is projected that by 
2030 there will be 1 billion obese adults in the world if no drastic measure are taken to slow this 
epidemic (Yang et al. 2008). 
 When focusing on the population in the United States, the Centers for Disease Control 
and Prevention (CDC) have determined that over one-third of the adult population in the US is 
	  obese (Ogden et al. 2010). In 2010, 91 million Americans were considered obese or overweight 
(Ogden et al. 2010). The growing trend towards obesity has become a critical problem in the US, 
especially given the large number of health implications that have been linked with having 
overweight/obese status.  A higher propensity to develop cardiovascular disease (CVD) has been 
identified through increased cases of hypertension and atherosclerosis (Lavie et al. 2009). Insulin 
resistance, which has been linked to development of type II diabetes, also has a higher likelihood 
to develop in the obese (Karpe et al. 2011). Individuals with higher BMIs have been identified to 
have higher ratios for death from any cause when compared to those with normal BMIs (Zheng 
et al. 2011). A study conducted with 900,000 subjects found that every 5-point increase on BMI 
was on average associated with about 30% higher overall mortality (Whitlock et al. 2009). 
Currently, research is also exploring the immunosuppressant effects of obesity as 
immunocompetence is related to nutritional status. More specifically, the immune status of an 
obese individual is characterized by altered lymphocyte and monocyte functioning. Excess fat 
produces reduced leucocyte, neutrophil, monocyte, and lymphocyte counts, and lower T-cell 
mitogen-induced proliferation (Marti et al. 2001). This leads to increased susceptibility to 
bacterial and viral infection (Karlsson and Beck 2010). The link between obesity and the 
immune system has been found to be within the adipose tissue (Weisberg et al. 2003). Increased 
macrophage infiltration in adipose tissue is greater in obese and thus produces a pro-
inflammatory state that is associated with inflammation and reduced immune response 
(Weisberg et al. 2003, Lumeng et al. 2007).  The impaired immune response also stems from the 
fact that obesity compromises immune response pathways by producing accelerated age-related 
thymic involution, reduced naïve T-cell production, and reduced T-cell diversity (Yang et al. 
2009)  
	  Not only does obese status have significant negative health outcomes, but it also carries a 
hefty economical burden. It is estimated that $185.7 billion are spent annually in the US for 
medical costs related to obesity (Cawley and Meyerhoefer 2012). Also, medical costs for obese 
individuals are $3,115 higher than those for normal weight individuals (Cawley and Meyerhoefer 
2012). It has been estimated that if obesity trends follow its current track, obesity-related medical 
costs in the US could increase by $48-$66 billion per year (Wang et al. 2011).  
 Influenza is a serious public health concern as it causes severe illness around the world. It 
is an acute viral infection and it can spread easily from person to person. Every year, influenza 
results in 3 to 5 million cases and leads to 250,000 to 500,000 deaths worldwide (WHO 2014). 
During the A/H1N1/2009 pandemic, obesity was identified as an independent risk factor for 
influenza virus (Louie et al. 2011). In fact, obese individuals are at a greater risk for respiratory 
hospitalizations during seasonal flu periods (Kwong et al. 2011). A review of the literature has 
also shown that obese patients, hospitalized because of influenza, were at a higher risk of being 
admitted to the intensive care unit (ICU) and tended to remain in hospitals for longer periods of 
time (Rodriguez et al. 2011). Another published study found that in an animal model, obese mice 
who were infected with influenza virus had a 6.6 fold higher mortality rate post-infection and 
had delayed pro-inflammatory cytokine expression leading to a diminished immune response 
(Smith et al. 2007).  
Given that obesity appears to be related to greater complications and an overall slower 
recovery from influenza, it is important to identify the best strategies for preventing the spread of 
influenza virus, especially among obese individuals. Vaccination is the safest and most effective 
method for preventing the negative impacts of the disease (WHO 2014). Influenza vaccination 
functions by stimulating the production of antibody response to the antigen and by creating CD8+ 
	  T-cell response in cells (Sheridan et al 2012). CD8+ T-cells have the capacity to destroy infected 
cells and defend the body against infection (Harty et al. 2000). However, there is evidence to 
believe that obesity impairs immunological response to influenza vaccination in humans. The 
CD8+ T-cell response is impaired in obese populations (Sheridan et al. 2012). Studies indicate 
that although the influenza vaccine generates the CD8+ T-cell response, there is a vast reduction 
of the percentage of these cells among obese individuals (Karlsson et al. 2010). IFNy and 
granzyme B, two proteins and markers of the activity of CD8+, were also significantly reduced 
among obese who were vaccinated with trivalent influenza vaccine (Sheridan et al. 2012). 
Granzyme B assists in the destruction of infected cells, while IFNy inhibits viral replication. 
Additionally, antibody titers are also impaired when obese individuals are vaccinated. Although 
there is an initial elevated antibody response to influenza vaccination, this trend is not upheld 
throughout the entire period that influenza is infecting the population (Sheridan et al. 2012). A 
study indicated an initial heightened antibody response to trivalent influenza vaccine, but after 12 
months, the antibody levels for obese decreased by more than 4-fold in over 50% of the obese 
patients. Contrastingly, among normal weight individuals, the decrease of 4-fold only occurred 
in less that 25% of the patients (Sheridan et al. 2012). As can be seen, the vaccine is not as 
protective and thus leaves a growing obese population with suboptimal protection from the 
influenza virus.  
 There are many lifestyle factors that can have great benefits to producing a robust 
immune system. Most notable are participating in an active lifestyle and/or consuming a varied 
and healthy diet. It is recommended by the 2008 Physical Activity Guidelines for Americans that 
adults get 150 minutes of moderate intensity aerobic activity every week and muscle strength 
training on 2 or more days or that they get 75 minutes of vigorous intensity aerobic activity and 
	  muscle strength training on 2 or more days (CDC 2008). The positive impact of physical activity 
is instrumental to the body; it reduces risk of developing CVD, type II diabetes, hypertension, 
obesity, and some cancers (Melzer et al. 2004). Additionally, participation in constant physical 
activity has been linked with enhancing immune response. Partaking in physical activity has 
been found to be predictive of greater beta andrenergic receptor responsivity (Hong et al. 2013). 
With greater responses come lowered pro-inflammatory cytokine levels, which are instrumental 
in activated immune systems (Hong et al. 2013). Additionally, bouts of moderate aerobic 
exercise (30min/day for 5days/week for 3 weeks) have been studied and show improved 
macrophage innate immune function (Kizaki et al. 2008). A review of the literature also indicates 
that even in obese and overweight individuals, having higher levels of cardio-based fitness 
reduced chronic immune activation and inflammation (Hong et al. 2013).  Regular physical 
activity has also been linked with enhanced influenza vaccine response. It has been found that 
influenza-vaccinated older adults who participated in a 10-month exercise regimen had enhanced 
antibody titers and IFNy production when compared to sedentary patients (Kohut et al. 2004). In 
another study, an association was found between physical activity and immune response to 
influenza immunization. Among older adults who were classified as physically active, 
moderately active, or sedentary, the active seniors had higher anti-influenza IgG and IgM and 
greater influenza specific lymphocyte proliferation than sedentary individuals (Kohut et al 2002).  
Literature providing support for associations between healthful diets and enhanced 
immune response in obese individuals is limited, however some studies have been able to show a 
slight link between the two. A recent study investigating the connection between immune-
compromised individuals and more nutrient-rich foods (whole grains, vegetables, fruits 
compared to added fats, sugars, and oils) provided enough evidence to link high quality nutrition 
	  to better health outcomes (Rawat et al. 2013). In another study with overweight and obese 
postmenopausal women, results indicated some evidence that healthy eating patterns contributed 
to improved immune function and reduced inflammation (Boynton et al. 2007). Diets that are 
calorie dense and high with fat are associated with increased thymic involution, which results in 
decreased T-cell levels and diversity and thus leads to decreased immune response (Yang et al. 
2009). Fruits and vegetables contain fiber, antioxidants, flavonoids, vitamin A, vitamin E, and 
many additional essential vitamins and nutrients (Deivert and Fleetwood 2013). When the 
immune system is activated, pro-inflammatory cytokines and reactive oxygen species are 
activated to create a primary defense against pathogens; however over-inflammation causes the 
immune response to be impaired. Through the consumption of nutrient rich foods, many of the 
nutrients and vitamins are able to act to reduce oxidative stress and inflammation, and are also 
able to increase activation of T-cells and antibodies (Mahima et al. 2013, Pae et al. 2011).  
There is little research regarding the positive effects of maintaining a healthy lifestyle on 
the effectiveness of vaccine response among obese individuals. There is an argument that 
individuals who are obese, yet have a regular exercise regime, are metabolically normal when 
compared with obese, non-exercising individuals (Karelis 2008). These obese individuals have 
favorable metabolic profiles marked by high insulin sensitivity, no hypertension, and normal 
levels of lipids, hormones, and inflammation (Aguilar Salinas et al. 2008, Brochu et al. 2001, 
Karelis et al. 2005). In fact, the metabolic profiles of the obese metabolically healthy individuals 
are almost identical to those of young and lean individuals (Dvorak et al. 1999). An important 
question that seems unresolved is the effect that a positive quality diet in obese individuals has 
on metabolic effects. A review of the literature found no support for either a positive or negative 
association between diet quality and metabolic profile. Because of the lack of research data 
	  describing the impact of healthy behaviors among obese individuals on flu vaccine integrity, this 
project will compare obese individuals who are either following healthy diet and physical 
activity practices or unhealthy ones and additionally compare how their health practices status 
affects flu vaccine responses. All in all, the purpose of this study will be to identify the impact of 
positive diet and physical activity behaviors on the effectiveness of the influenza vaccine in 
obese adults. I hypothesize that obese individuals who report an exercise regime and healthy diet 
quality will have improved vaccine responsiveness compared with the obese subjects who are 
not currently exercising or eating a good quality diet. In order to address the purpose of this 
study, three specific aims were created. 
 
Aim 1: Compare the IgG antibody titer response to the flu vaccine in a group of obese 
individuals who are classified as ‘healthy’ (4th quartile of a diet and physical activity health 
behavior screener) to those classified as ‘unhealthy’ (1st quartile). It is hypothesized that 
individuals in quartile 4, obese with healthy lifestyles, will have a larger percent increase in IgG 
antibodies from pre to post vaccination when compared to obese with unhealthy lifestyles in 
quartile 1.   
 
Aim 2: Compare the IgG antibody titers for obese individuals with physical activity levels of 
‘Low Active’ and ‘High Active.’ It is hypothesized that obese individuals who are classified as 
high active based on a physical activity screener will have larger increase in IgG antibody titers 
from pre to post vaccination when compared to obese adults who are classified as low active 
from the screener. 
 
	  Aim 3:  Compare the IgG antibody titers for obese individuals with high quality and low quality 
diets. It is hypothesized that obese individuals who are classified as having a high quality diet 
will have a larger increase in IgG antibody titers from pre to post vaccination compared to obese 
adults who are classified as having a low quality diet. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  CHAPTER 2 
METHODS 
 
Subjects: 
Eligible patients at least 18 years of age were recruited from the University of North Carolina at 
Chapel Hill Family Medicine Center (FMC) during their flu vaccine appointment. Since all 
participants were drawn from their primary medical care facility, detailed medical records were 
available for all subjects. For this study, exclusion criteria included immunosupression, self-
reported history of prior influenza vaccination for current season, acute febrile illness, treatment 
with immunomodulator or immunosuppressive drugs, being pregnant, being non-obese (BMI 
less than 30 kg/m2), being diagnosed with type I or type II diabetes, not identifying as African-
American, African, or Caucasian, and being a non-English speaker. A final analytical sample of 
132 subjects (N=132) was obtained. These individuals were then categorized based on combined 
diet and PA scores into 2 quartiles for health (obese healthy and obese unhealthy). The individual 
scores were first standardized using z-scores. The diet z-score and the physical activity z-score 
were added to create a “combined diet and PA z-score.” These scores were then sorted into 4 
groups based on quartiles. The highest and lowest quartiles were identified to create the obese 
healthy and unhealthy groups. Stratified random sampling was used to obtain a random sample 
of 40 patients, 20 in the healthy obese quartile and 20 in the unhealthy obese quartile. During 
ELISA assays, 1 subject from the unhealthy quartile was thrown out given failed ELISA assay. 
This left a final sample size of 39 subjects (n=39). 
 
Study Design: 
	  This single site, prospective study was carried at UNC FMC as part of an ongoing NIH funded 
clinical trial (IRB# 08-1606, M. Beck, PI). Subjects were recruited through a flier included in 
mailed appointment reminders for flu shot clinic visits, by posted flyers at the FMC, and use of a 
Research Coordinator (RC) at the FMC during flu vaccine season (October through March). 
Upon consenting to be a part of the study, RC obtained a pre-vaccination serum sample and 
administered the CDC inactivated trivalent influenza virus vaccine to the deltoid muscle. 
Approximately 30-days post vaccination, another blood draw was obtained from study 
participants. In order to collect information about diet, a brief 10-question diet screener was 
developed for this study and validated in a sub-study. The developed diet screener and a physical 
activity screener were administered during initial clinic visit and results were filed. The serum 
that was collected was stored at -80˚C until analyzed. Information about the diet survey and 
physical activity screener are described in the sections below.  
 
Measurement of serum IgG antibody titers: 
Serum IgG vaccine antibodies were determined via enzyme-linked immunosorbent assay 
(ELISA). The vaccine was diluted with coating buffer and adsorbed to a 96-well falcon plate. 
The vaccine was diluted 1:160 for IgG1-4 and 1:320 for IgG total in the coating buffer and was 
added to the wells on the plate and incubated overnight at 4˚C. Immediately following, the cells 
were blocked using 200µL/well of Block Buffer. The plate was left to incubate for 1 hour at 
37˚C. The wells were washed 3x2 with Phosphate Buffered Saline (PBSt). The serum samples 
were diluted and left incubating for 2 hours at 37˚C. The wells were once again washed 3x2 with 
PBSt. Dilutions of goat anti-human IgG conjugated to horseradish peroxidase were formed in 
Dilution Buffer and 50µL were added to each well. The plate was incubated for 1 hour at 37˚C. 
	  The plate was washed 3x2 with PBSt and dried. 100µL of TMB Substrate Solution Mix was 
added to each well and was incubated for 30 minutes at room temperature. The reaction was 
stopped with 100µL of 2M Sulfuric Acid. The absorbance was read at 450 nm. 
 
Measurement of Health Habits: 
Sub-study: Dietary Screener Development and Validity Test 
Lack of a suitable diet quality screener required that a new measure be developed and evaluated 
for use in this research study. The purpose of the diet screener was to assign ‘diet scores’ for 
subjects in the Influenza vaccine responsiveness study described above.  
A diet score was created from the brief 10-question screener with 5 questions addressing positive 
diet habits and 5 questions addressing negative diet habits. The screener was created based on 
questions from already established diet-screeners and included information about consumption of 
sugar-sweetened beverages, excess alcohol, high-fat snacks, fast food consumption, as well as 
consumption of fruits, vegetables, dairy products, and whole grains. The negative diet habit 
questions were scored in reverse. In order for a score to be minimally acceptable, participant 
must have answered at least 4 of the 5 positive diet questions and at least 4 of the 5 negative diet 
questions had to be answered as well. Each questions was scored on a 1 to 5 range and the point 
value for each question was added and divided by the number of questions answered to provide a 
‘diet score.’  
In order to validate the results of the screener, participants were recruited through electronic 
announcements via listservs and emails (protocol approved by the UNC IRB). Upon meeting 
eligibility criteria, subjects were asked to complete the 10-question diet questionnaire and to 
provide basic demographic information (age, race, sex), as well as self-perception of diet and 
	  health. This survey was created and administered through Qualtrics, and online survey software. 
Eligible subjects were between 18 to 65 years of age and were recruited through electronic 
announcements through listservs and email. Subjects also had to be fluent in English. No 
restriction on race or ethnicity were determined. For this sub-study a final analytical sample of 
111 subjects (N=111) was obtained.  
Physical Activity Level Measurement:  
Physical activity scores for obese individuals (BMI greater than or equal to 30 kg/m2) were 
calculated. For this study, the Rapid Assessment of Physical Activity (RAPA) screener was used 
to attain a ‘physical activity score.’ RAPA was developed to categorize subjects into either high 
and low activity levels (Topolski et al 2006). A score of 3 indicated that participants were 
active/meeting guidelines, a score of 2 designated them as irregular active, and a score of 1 
designated inactivity.  
 
Statistics/Analysis: 
All data was analyzed using SAS 9.3 (SAS Institute, Cary, NC). For the screener validation 
study, a Cronbach alpha test was conducted to provide a measure for reliability and internal 
consistency for the created diet screener. Additionally, two ANOVA tests were utilized to assess 
the relationship between the average diet scores and responses to self-perceived health and diet 
questions. Lastly, a discriminant validity test was used to find the correlation between diet score 
and BMI. For the study focusing on influenza vaccine responsiveness, an independent t-test was 
conducted to assess the significance and compare the differences in percent change of IgG 
subclass by group. The results of the diet screener development and validity tests will be 
presented first, followed by the results from the influenza vaccine response study. 
	  CHAPTER 3 
RESULTS 
 
Development of Diet Screener: 
A sub-study was conducted to assess the validity of the 10-question nutrition screener that was 
developed to obtain a measure of diet quality that was needed as part of the health status score. 
The sample included 111 participants with an average age of 29.8 y, who were 74% female and 
85% Caucasian. The ages ranged from 18 to 61 years of age. The racial breakdown was 0.9% 
American Indian (1 Subject), 3.6% Asian (4 subjects), 2.7% African American (3 Subjects), 
0.9% Native Hawaiian or Pacific Islander (1 subject), 84.7% Caucasian (94 subjects), and 6% 
other (8 Subjects). 19.8% of participants identified as Hispanic (22 subjects). The Body Mass 
Index (BMI) ranged from 16.5 to 40.4. The mean BMI was 23.1 (4.1).  
Participants were asked to rate their overall health status by this question: “How would you rate 
your health?” with response choices including ‘Bad’, ‘Normal’, and ‘Good.’ A score of 1 
indicated a bad health status, a score of 2 indicated a normal health status, and a score of 3 
indicated a good health status. The mean rating was of 2.68 (0.51).  Participants were also asked 
to rate their diet compared to that of the average American (In general my diet is _______ than 
the average American). A score of 1 indicated a diet that was worse, a score of 2 indicated a diet 
that was the same, and a score of 3 indicated a diet that was better. The mean score was found to 
be 2.77 (0.49). Table 1 provides a breakdown of the summary characteristics of the population 
sample.  
Table 1: Characteristics of Subjects in Nutrition Screener Validity Study, United 
States, 2014 
Characteristics Patients, No. (%) 
Sex:   
	  Male 29 (26.1) 
Female 82 (73.9) 
Race:  
American Indian 1   (0.9) 
Asian 4   (3.6) 
African American 3   (2.7) 
Native Hawaiian/Pacific Islander 1   (0.9) 
Caucasian 
Other                  
94 (84.7) 
8   (7.2) 
Ethnicity:  
Hispanic  22 (19.8) 
Non – Hispanic 89 (80.2) 
Age:  
18 – 28  72 (64.9) 
29 – 39 12 (10.8) 
40 – 50 14 (12.6) 
51 – 61 13 (11.7) 
Diet Perception Rating:  
Worse than the average American 3   (2.7) 
Same as the average American 20 (18.0) 
Better than the average American 88 (79.3) 
Health Perception Rating:  
Bad 
Normal 
Good 
2   (1.8) 
32 (28.8) 
77 (69.4) 
BMI:  
15-20 
21-25 
26-30 
31-35 
36-40 
36 (32.4) 
58 (52.3) 
11 (9.9) 
4 (3.6) 
2 (1.8) 
 
 
A Cronbach α test was performed on the responses generated from the 10-question nutrition 
screener. This test was chosen in order to provide a measure of internal consistency and 
reliability in the produced measurement instrument. A Chronbach α value greater than 0.6 can be 
judged as acceptable (Vinzi et al. 2010) and for this study a value of α = 0.64 was found 
indicating acceptable internal consistency which can be considered as a measure of the 
instrument’s reliability.  
	  A second analysis was performed on the data in order to determine the association between the 
calculated average diet score with the perceived health rating and the calculated average diet 
score with the self-perceived diet status when compared to the average American. A one-way 
analysis of variance (ANOVA) was calculated for the health rate. The results were F(2,108) = 
2.73, p = 0.07 and are showing a trend towards significance. Although the results indicate that 
there is no statistical difference between the means of the three categories, the calculation of the 
means for each health category indicate diet scores increase as perceived health becomes more 
positive. Subjects who rated their health status as low (score of 1) had a mean diet score of 3.35 
(1.06). Subjects who identified with a normal health status (score of 2) had a mean diet score of 
3.55 (0.66). Subjects who identified with a good health (score of 3) status had a mean diet score 
of 3.79 (0.45). Figure 1 displays this relationship. 
An ANOVA was also calculated comparing participants’ diet score compared to the average 
American.  The results were significant, F(2,108) = 6.94, p = 0.002 and as a result identify that 
there is a statistically significant difference between the means of each of the perceived diet 
categories. Subjects who felt that their diet was worse than that of the average American (score 
of 1) had a mean diet score of 3.10 (0.53), while subjects who identified their diet as the same 
(score of 2) had a mean diet score of 3.41 (0.62). Subjects who identified with a diet that was 
better than that of the average American (score of 3) had a mean diet score of 3.80 (0.48). Figure 
2 displays this relationship. 
Lastly, the correlation between diet score and BMI was calculated using a discriminant validity 
test. The results found a correlation of r = -0.13, p = 0.10 and a trend towards significance. 
Although the results indicate that there is no statistical correlation between BMI and diet score, 
	  the results are representative of the inverse relationship between the two. As the diet score 
increased the BMI decreased and vice versa. Figure 3 displays this relationship. 
 
 
 
 
 
 
 
 
 
Figure 1. This figure represents the mean diet score based on the perceived health status indicated by the 
the individuals. A perceived health status score of 1 indicates a bad health status, a score of 2 indicates a 
normal health status, and a score of 3 indicates a good health status. Diet scores range from 1 to 5, with 1 
indicating a low quality diet and a score of 5 indicating a high quality diet. 
 
 
 
 
 
 
 
 
 
	  Figure 2. This figure represents the mean diet score based on the perceived diet indicated by the the 
individuals. A perceived diet score of 1 indicates a diet that was worse than that of the average American, 
a score of 2 indicates a diet that is the same as that of the average American, and a score of 3 indicates a 
diet that is better than that of the average American. Diet scores range from 1 to 5, with 1 indicating a low 
quality diet and a score of 5 indicating a high quality diet. 
 
 
 
 
 
 
 
 
 
Figure 3. This figure represents the inverse trend between diet scores and BMI. A higher diet score 
correlates with a lower BMI. As the diet score decreases, the BMI becomes higher. A figure represents 
data from 111 subjects (N=111).  
 
Effectiveness of Flu Vaccine 
The second part of the results will focus on presenting data and trends found when assessing the 
impact of health status and positive diet and physical activity behaviors on the effectiveness of 
the influenza vaccine in obese adults.  
In this sample there were 39 participants (originally 40, but data for one participant was 
unusable) whose ages ranged from 20 to 74 years with a mean age of 51.3 years (12.0).  Of 
	  these, 30.8% (12 subjects) were male. The racial breakdown was 66.7% Caucasian (26 subjects) 
and 33.3% African American/African (13 subjects). The Body Mass Index (BMI) ranged from 
30.2 to 56.7, with a mean of 37.6 (7.7). 
The 10-question nutrition screener from the sub-study was used to calculate a diet score. The 
scoring ranged from 1-5 with a score of 5 signaling the high quality diet and a score of 1 
indicating a low quality diet. The mean score for these participants was 3.3 (0.8). To assess 
physical activity levels RAPA was used (Topolski et al. 2006). The scoring ranged from 1-3 with 
a score of 3 designating active/meeting guidelines, a score of 2 designating irregular active, and a 
score of 1 designating inactivity physical activity status. The mean PA score for these 
participants was 2.1 (0.9). Based on the data from the combined diet and PA scores, a ‘healthy’ 
(obese with healthy lifestyle, n=20) and an ‘unhealthy’ groups (obese with an unhealthy lifestyle, 
n=19) were formed.  
For the Obese/Unhealthy lifestyle practices group, there were 19 participants whose ages ranged 
from 32 to 74 years with a mean age of 54.4 years (10.1). Of these, 31.6% (6 subjects) were 
male. The racial breakdown was 68.4% Caucasian (13 subjects) and 31.6% African 
American/African (6 subjects). The Body Mass Index (BMI) ranged from 30.2 to 53.2, with a 
mean of 37.0 (6.4). The mean diet score was 2.74 (0.69). The mean PA score was 1.26 (0.45). 
For the Obese/Healthy lifestyle practices group, there were 20 participants whose ages ranged 
from 20 to 67 years with a mean age of 48.3 years (13.1). Of these, 30.0% (6 subjects) were 
male. The racial breakdown was 65.0% Caucasian (13 subjects) and 35.0% African 
American/African (7 subjects). The Body Mass Index (BMI) ranged from 30.2 to 56.7, with a 
mean of 38.2 (8.9). The mean diet score was 3.82 (0.54). The mean PA score was 2.85 (0.37). 
Table 2 provides a breakdown of the summary characteristics of the study population.  
	  Table 2: Characteristics of Subjects in Flu Vaccine Effectiveness Study, United States, 2014 
Characteristics Overall, No. (%) Healthy, No. (%) Unhealthy, No. (%) 
Sex:    
Male 12 (30.8)   6 (30.0)   6 (31.6) 
Female 27 (69.2) 14 (70.0) 13 (68.4) 
Race:    
Caucasian 26 (66.7) 13 (65.0) 13 (68.4) 
    African American 13 (33.3)   7 (35.0)   6 (31.6) 
Age:    
20 – 30  2 (5.1) 2 (10.0) 0 (0.0) 
31 – 41 6 (15.4) 4 (20.0) 2 (10.5) 
42 – 52 11 (28.2) 5 (25.0) 6 (31.6) 
53 – 63 15 (38.5) 8 (40.0) 7 (36.8) 
64 – 74 5 (12.8) 1 (10.0) 4 (21.1) 
BMI:    
30-35 20 (50.0) 10 (50.0) 10 (52.6) 
36-40 8 (20.0) 3 (15.0) 5 (26.3) 
41-45 6 (15.0) 4 (20.0) 2 (10.5) 
46-50 1 (2.5) 0 (0.0) 1 (5.3) 
51-55 3 (7.5) 2 (10.0) 1 (5.3) 
56-60 1 (2.5) 1 (5.0) 0 (0.0) 
Diet Score Average 3.30 3.82 2.74 
Physical Activity 
Score Average 
2.08 2.85 1.26 
 
The IgG titer levels were examined for each of the two groups. All data for IgG2 were not 
included in this analysis because the changes in titer levels were so small and the ELISA test was 
not sensitive enough to produce useful results.  
For all the distinct titers, pre and post vaccination IgG absorbance levels were determined. 
Subjects were stratified by lifestyle (unhealthy and healthy) and the means IgG absorbance for 
pre- and post-vaccination were calculated. For the unhealthy lifestyle group, mean pre-
vaccination IgG total absorbance was 1.805 (0.438). The mean post-vaccination IgG total 
absorbance was 2.387 (0.394). For the healthy lifestyle group, the mean pre-vaccination IgG 
total absorbance was 1.504 (0.551). The mean post-vaccination IgG total absorbance was 2.174 
(0.569). Results for IgG total are represented in Figure 4.  
	   
 
 
 
 
 
 
 
 
Figure 4. Mean IgG total absorbance levels for obese with healthy and unhealthy lifestyles. A higher 
absorbance indicates a higher presence of IgG total antibodies.  
 
The same analysis was preformed for the other three titers: IgG1, IgG3, and IgG4. For IgG1, the 
unhealthy lifestyle group mean pre-vaccination IgG1 absorbance was 1.540 (1.071). The mean 
post-vaccination IgG1 absorbance was 2.001 (1.183). For the healthy lifestyle group, the mean 
pre-vaccination IgG1 absorbance was 1.658 (0.852). The mean post-vaccination IgG1 
absorbance was 2.342 (0.776). Results for IgG1 are represented in Figure 5. For IgG3, the 
unhealthy lifestyle group mean pre-vaccination IgG3 absorbance was 0.945 (0.725). The mean 
post-vaccination IgG3 absorbance was 1.545 (0.999). For the healthy lifestyle group, the mean 
pre-vaccination IgG3 absorbance was 1.040 (0.930). The mean post-vaccination IgG3 
absorbance was 1.559 (0.891). Results for IgG1 are represented in Figure 6. For IgG4, the 
unhealthy lifestyle group mean pre-vaccination IgG4 absorbance was 0.372 (0.512). The mean 
post-vaccination IgG4 absorbance was 0.587 (0.736). For the healthy lifestyle group, the mean 
	  pre-vaccination IgG4 absorbance was 0.325 (0.376). The mean post-vaccination IgG4 
absorbance was 0.553 (0.658). Results for IgG1 are represented in Figure 7.  
 
 
 
 
 
 
 
 
 
Figure 5. Mean IgG1 absorbance levels for obese with healthy and unhealthy lifestyles. A higher 
absorbance indicates a higher presence of IgG1 antibodies. 
 
 
 
 
 
 
 
 
 
Figure 6. Mean IgG3 absorbance levels for obese with healthy and unhealthy lifestyles. A higher 
absorbance indicates a higher presence of IgG3 antibodies.  
	   
 
 
 
 
 
 
 
 
Figure 7. Mean IgG4 absorbance levels for obese with healthy and unhealthy lifestyles. A higher 
absorbance indicates a higher presence of IgG4 antibodies.  
 
Next, the percent change of IgG absorbance between pre and post vaccination was calculated for 
each of the lifestyle categories in each of the 3 IgG subclasses and for IgG total. For IgG total, 
the mean percent change in IgG total levels pre- and post-vaccination in the unhealthy group was 
43.83% (13.73) and in the healthy group it was 63.92% (17.00). There was a greater percent 
change in the healthy group. For IgG1, one subject was eliminated from analysis from the 
unhealthy category since it was an outlier (the recorded percent change for this value was 
2,377%, which was largely due to a calculation that included a baseline titer too low to be read 
by the ELISA assay). This left a total analytical sample of 18 (n=18) in the unhealthy group and 
19 (n=19) for the healthy group. The mean percent change in IgG1 levels pre- and post-
vaccination in the unhealthy group was 57.98% (33.95) and in the healthy group it was 69.87% 
(19.93). There was once again a greater percent change in the healthy group. For IgG3, two 
subjects were eliminated from analysis due to being outliers. One was from the unhealthy 
	  category and the other from the healthy one. The recorded percent change for these values were 
53,900% and 379,900%, which were largely due to calculation that included a baseline titer too 
low to be read by the ELISA assay. This left a total analytical sample of 18 (n=18) for the 
unhealthy group and 19 (n=19) for the healthy group. The mean percent change in IgG1 levels 
pre- and post-vaccination in the unhealthy group was 130.80% (49.30) and in the healthy group 
it was 120.60% (47.16). There was a slightly greater percent change in the unhealthy group. For 
IgG4, three subjects were eliminated from analysis from the unhealthy category since they were 
outliers. The recorded percent change for these values were 2,200%, 3,126%, and 4,900% and 
were largely due to calculations that included baseline titers too low to be read by the ELISA 
assay. This left a total analytical sample of 16 (n=16) for the unhealthy group. The mean percent 
change in IgG4 level pre- and post-vaccination in the unhealthy group was 2.54% (24.57) and in 
the healthy group it was 167.20% (37.39). There was once again a greater percent change in the 
healthy group. The results are displayed in figure 8.    
 
 
 
 
 
 
 
 
 
Figure 8. Percent change between pre and post vaccine IgG levels in unhealthy and healthy groups. A 
larger percent change indicates a better response to vaccine. 
	  An independent t-test was conducted to compare the differences in percent change of IgG 
subclass by group. Results for IgG total indicated a non-significant trend in the predicted 
direction indicating that there was a difference in the percent change of IgG levels pre and post 
vaccination, t(37) = 0.91, p = 0.37. These results suggest that obese individuals who have healthy 
lifestyles are trending towards having a greater response to the influenza vaccine. Results for 
IgG1 indicated a non-significant trend in the predicted direction indicating that there was a 
difference in the percent change of IgG levels pre- and post-vaccination, however these 
differences were not statistically different, t(36) = 0.31, p = 0.76. Results suggest that obese 
individuals who have healthy lifestyles have a greater response to the influenza vaccine. Results 
for IgG3 indicated a non-significant trend in the opposite direction indicating that there was a 
difference in the percent change of IgG levels pre and post vaccination, t(35) = 0.15, p = 0.88.  
Results for IgG4 indicated a non-significant trend in the predicted direction indicating that there 
was a difference in the percent change of IgG levels pre and post vaccination, t (34) = 1.33, p = 
0.193. Results suggest that obese individuals who have healthy lifestyles have a greater response 
to the influenza vaccine.  
Following, an exploratory analysis was performed comparing IgG levels and physical activity 
status to see the effects physical activity alone had on vaccine response in obese adults. For the 
unhealthy group a median split was conducted dividing into more or less active. All subjects who 
marked a physical activity level of 1 were categorized as ‘low active’ while all who marked a 
physical activity of 2 were identified as ‘high active’. The mean IgG level for each of the 
subclasses was performed for both the high and low active groups. A similar analysis was 
conducted in the healthy category. In this group a physical activity score of 2 was identified as 
‘low active’ while a score of 3 was identified as ‘high active’. The extremes of physical activity 
	  were compared: from the unhealthy category those who were ‘low active’ (n=14) were compared 
to the ‘high active’ individuals (n=16) from the healthy category. Results are displayed in figure 
9, 10, 11, and 12.  
 
 
 
 
 
 
 
 
 
Figure 9. Mean IgG total absorbance levels for obese with low and high physical activity levels. A higher 
absorbance indicates a higher presence of IgG total antibodies. The mean pre-vaccination IgG absorbance 
level for low active group was 1.911 (0.428). The mean post-vaccination IgG absorbance level for this 
group was 2.344 (0.233). The mean pre-vaccination IgG absorbance for the high active group was 1.552 
(0.551) and the mean IgG absorbance for the post-vaccination group was 2.241 (0.572).  
 
 
 
 
 
 
	   
Figure 10. Mean IgG1 absorbance levels for obese with low and high physical activity levels. A higher 
absorbance indicates a higher presence of IgG1 antibodies. The mean pre-vaccination IgG absorbance 
level for low active group was 1.588 (1.027). The mean post-vaccination IgG absorbance level for this 
group was 1.993 (1.157). The mean pre-vaccination IgG absorbance for the high active group was 1.64 
(0.801) and the mean IgG absorbance for the post-vaccination group was 2.424 (0.641).  
 
 
 
 
 
 
 
 
 
Figure 11. Mean IgG3 absorbance levels for obese with low and high physical activity levels. A higher 
absorbance indicates a higher presence of IgG3 antibodies. The mean pre-vaccination IgG absorbance 
level for low active group was 1.017 (0.657). The mean post-vaccination IgG absorbance level for this 
group was 1.683 (0.937). The mean pre-vaccination IgG absorbance for the high active group was 1.096 
(0.988) and the mean IgG absorbance for the post-vaccination group was 1.616 (0.903).  
	   
 
 
 
 
 
 
 
 
Figure 12. Mean IgG4 absorbance levels for obese with low and high physical activity levels. A higher 
absorbance indicates a higher presence of IgG4 antibodies. The mean pre-vaccination IgG absorbance 
level for low active group was 0.485 (0.557). The mean post-vaccination IgG absorbance level for this 
group was 0.67 (0.774). The mean pre-vaccination IgG absorbance for the high active group was 0.378 
(0.403) and the mean IgG absorbance for the post-vaccination group was 0.665 (0.693).  
 
The percentage change between the pre- and post-vaccination IgG Absorbance based on the 
physical activity level was also calculated. The percentage change was greater in the high active 
group for all of the IgG subclasses. The results are displayed in figure 13. 
 
 
 
 
 
 
	   
 
 
 
 
 
 
 
 
 
Figure 13. Percent change of IgG absorbance level in obese adults stratified by physical activity level. A 
larger percent change indicates a better response to vaccine.  
 
A second exploratory analysis was preformed on IgG levels and diet quality to see the 
effects diet alone had on vaccine response in obese adults. For the unhealthy group a median 
split was conducted dividing into high or low quality diets. All subjects who had a calculated diet 
score of 2.5 or less were categorized as consuming a ‘low quality diet’ while all who had a diet 
score of 2.6 or greater were identified as having a ‘high quality diet’.  The mean IgG level for 
each of the subclasses was performed for both the high and low quality diet groups. A similar 
analysis was conducted in the healthy category. In this group a diet score of 3.6 or less was 
identified as ‘low quality diet’ while a score of 3.7 or greater was identified as ‘high quality 
diet’. The extremes of diet quality were compared: from the unhealthy category those who had 
‘low quality diets’ (n=8) were compared to those who had ‘high quality diet’ individuals (n=9) 
from the healthy category. Results are displayed in figure 13, 14, 15, and 16.  
	   
 
 
 
 
 
 
 
 
Figure 13. Mean IgG total absorbance levels for obese with low and high quality diets. A higher 
absorbance indicates a higher presence of IgG total antibodies. The mean pre-vaccination IgG absorbance 
level for low quality diet group was 1.544 (0.297). The mean post-vaccination IgG absorbance level for 
this group was 2.469 (0.579). The mean pre-vaccination IgG absorbance for the high quality diet group 
was 1.209 (0.527) and the mean IgG absorbance for the post-vaccination group was 2.076 (0.788).  
 
 
 
 
 
 
 
 
 
	  Figure 14. Mean IgG1 absorbance levels for obese with low and high quality diets. A higher absorbance 
indicates a higher presence of IgG1 antibodies. The mean pre-vaccination IgG absorbance level for low 
quality diet group was 1.550 (1.259). The mean post-vaccination IgG absorbance level for this group was 
1.975 (0.578). The mean pre-vaccination IgG absorbance for the high quality diet group was 1.691 
(0.829) and the mean IgG absorbance for the post-vaccination group was 2.428 (0.958).  
 
 
 
 
 
 
 
 
 
Figure 15. Mean IgG3 absorbance levels for obese with low and high quality diets. A higher absorbance 
indicates a higher presence of IgG3 antibodies. The mean pre-vaccination IgG absorbance level for low 
quality diet group was 0.774 (0.717). The mean post-vaccination IgG absorbance level for this group was 
1.373 (1.008). The mean pre-vaccination IgG absorbance for the high quality diet group was 0.901 
(0.687) and the mean IgG absorbance for the post-vaccination group was 1.544 (0.873).  
 
 
 
 
 
	   
 
 
 
 
 
 
 
 
Figure 16. Mean IgG4 absorbance levels for obese with low and high quality diets. A higher absorbance 
indicates a higher presence of IgG4 antibodies. The mean pre-vaccination IgG absorbance level for low 
quality diet group was 0.332 (0.664). The mean post-vaccination IgG absorbance level for this group was 
0.476 (0.707). The mean pre-vaccination IgG absorbance for the high quality diet group was 0.354 
(0.429) and the mean IgG absorbance for the post-vaccination group was 0.631 (0.748).  
 
The percentage change between the pre- and post-vaccination IgG Absorbance based on the diet 
quality was also calculated. The percentage change was greater in the high quality diet group for 
all of the IgG subclasses. The results are displayed in figure 17. 
 
 
 
 
 
 
	   
 
 
 
 
 
 
 
 
Figure 17. Percent change of IgG absorbance level in obese adults stratified by diet quality. A larger 
percent change indicates a better response to vaccine.  
 
 
 
 
 
 
 
 
 
 
 
 
 
	  CHAPTER 4 
DISCUSSION 
 
With 5% to 20% of the population in the US infected with influenza every year, and with 
an increasing prevalence of obesity in this country, it is important to determine the relationship 
between obesity and immune response as it relates to influenza vaccination (WHO 2013, NIAID 
2012). The literature has provided many studies that have indicated that the obese individual is at 
greater risk for a more serious development of the influenza virus as obesity impairs the ability 
for the immune system to respond to the influenza virus effectively (Louie et al. 2009, Smith et 
al. 2007). Studies have examined the effects of the altered immune systems of obese populations 
and have identified several different hypotheses for the impaired ability to mount a protective 
immune response to the virus in this population, including reduced t-cell proliferation and 
diversity, reduced lymphocyte, monocyte, and leucocyte levels, increased macrophage 
infiltration in adipose tissue, and release of higher levels of pro-inflammatory adipokines 
(Sheridan et al. 2012, Marti et al. 2001, Weisberg et al. 2003, Paich et al. 2013, Yang et al. 2009, 
Perez de Heredia et al. 2012). Additionally, the literature has shown that obese individuals are 
also not as responsive to the influenza vaccine as elevated post-vaccination antibody levels are 
not upheld during the entire period that influenza is infecting the population (Sheridan et al. 
2012). Finding ways to create an enhanced response to the influenza vaccine in order to create 
heightened protection from influenza in this vulnerable population is critical. 
This study was the first to examine the impact of diet and physical activity lifestyles on 
the effectiveness of the influenza vaccine response in obese adult populations. The antibody 
levels pre- and post-influenza vaccination were analyzed in order to determine the percent 
	  change between obese individuals participating in high physical activity and consuming high 
quality diets, and obese individuals participating in low physical activity and consuming low 
quality diets. Although there were no significant findings between the differences between the 
percent change of IgG levels pre- and post-vaccination in the healthy and unhealthy lifestyle 
groups, the results indicate that there is a trend that enhanced physical activity and consumption 
of a high quality diet can minimize the decreased effectiveness of the influenza vaccine in obese 
adult populations. Although no other studies of this kind have been conducted, it can be 
speculated that this enhanced immune response results from the effects exercise and diet have on 
reducing low-grade inflammation and macrophage infiltration in adipose tissue. Several studies 
have explored this relationship and have found positive correlations between the two, which help 
to support our findings (Bruun et al. 2006, Vieira et al. 2009).  
We hypothesized those obese individuals with healthy lifestyle practices would exhibit 
higher percent changes in antibodies pre- and post-vaccination compared to obese adults with 
unhealthy lifestyle practices. As expected, the percent change in IgG total, IgG1, and IgG4 
exhibited a higher percent change in antibody levels in the healthy lifestyle group when 
compared to the unhealthy lifestyles group. However, there was a slightly higher percent 
increase in IgG3 levels for the unhealthy lifestyle group when compared to the healthy lifestyle 
one. An explanatory mechanism for this finding is not understood. 
Next, the exploratory analysis compared the effects of only physical activity on the 
effectiveness of the influenza vaccine. We hypothesized that obese individuals with high levels 
of physical activity would exhibit higher percent changes in antibodies pre- and post-vaccination 
compared to obese adults with low levels of physical activity. As expected, the percent change in 
all the IgG subclasses experienced a greater percent increase in the more physically active 
	  category of obese individuals. The positive correlation between increased exercise levels in 
populations and enhanced antibody response to the influenza vaccine has been noted in other 
studies (Kohut et al. 2002, Kohut et al. 2004) and thus supports the idea that exercise has the 
ability to reverse the immunosuppressant effects of obesity. Kohut et al. 2004 provided evidence 
to show that in	  general,	  subjects	  who	  participated	  in	  aerobic	  exercise	  three	  times	  a	  week	  for	  a	   10-­‐month	   period	   tended	   to	   show	   a	   larger	   increase	   in	   4-­‐week	   post-­‐immunization	   titer	  than	  subjects	  who	  did	  no	  exercise	  (Kohut	  et	  al	  2004).	  In	  fact,	  they	  found	  similar	  results	  to	  the	  ones	  found	  in	  this	  study,	  in	  that	  exercising	  individuals	  had	  an	  increased	  change	  in	  the	  antibody	  levels	  pre-­‐	  to	  post-­‐vaccination	  when	  compared	  to	  non-­‐exercising	  ones.	  (Kohut	  et	  al.	  2004).	    
Finally, diet quality alone was analyzed to see the effects that diet had on antibody levels 
pre- and post-vaccination. We hypothesized that obese individuals with high quality diets would 
have a greater response to the influenza vaccine marked by a larger percent increase in IgG 
antibody levels pre- and post-vaccination. As expected, the obese adults with higher quality diets 
exhibited an elevated antibody percent change than the obese adults with low quality diets. 
Although diet quality is hard to measure and a review of the literature resulted in no studies 
comparing the relationship of high quality diet with enhanced immune response specific to the 
influenza vaccine, other studies have identified that healthful diets have an association with 
overall enhanced immune response (Rawat et al. 2013, Boynton et al. 2007, Mahima et al, 2013, 
Pae et al. 2011) which support our findings.  
 Overall, the effects of physical activity alone had the largest positive impact on the 
effectiveness of the influenza vaccine when compared to diet alone and lifestyle (diet and 
physical activity combined).  
	  Limitations: 
 This study had several limitations. First, the interpretation and the analysis of the results 
are hampered by the small sample size for each of the lifestyle categories (n = 20 healthy 
lifestyles, n = 19 unhealthy lifestyles). Although the results were able to indicate data that were 
trending towards significance, the difference in percent change of IgG levels pre and post 
vaccination could have been found to be statistically significant had their been more samples in 
each of the lifestyle categories. Secondly, the classification of individuals into the lifestyle 
quartiles was administered using a self-designed diet screener and a short physical activity 
screener. The screeners used were not necessarily the best method for identifying lifestyle 
patterns based on the short number of questions that were asked. Additionally, the scoring used 
for the PA screener was self-designed and minimally tested, thus provided for more limitations. 
Longer and more highly validated screeners could have been used to provide more accurate 
assessments of diet quality and physical activity, but more lengthy measure could have impacted 
patient willingness to participate. Additionally, the study did not take into account the impact 
that race can have on immune response. Measures were taken to isolate only individuals who 
identified as Caucasian or African American/African for the study population, however between 
these two races immune response to vaccination could vary. Studies have shown that cytokine 
response following vaccination are influenced by race and ethnicity (Haralambieva et al. 2013, 
Haralambieva 2014). However, it was not possible to analyze this data separately by race. 
 
Future Studies: 
Future studies should further study the relationship between lifestyle practices in obese 
adults and response to the influenza vaccine. The results from this study help identify trends that 
	  occur in vaccine responsiveness due to the effects of physical activity and diet, however they do 
not provide statistically significant findings. Future studies should use a larger sample size and 
look into using more highly validated measures for assessing lifestyle practices. Additionally, 
since a higher percent change was found in the physical activity analysis alone, the effects of 
varying types of physical activity should be examined (aerobic vs resistance training). The 
impacts of further research in this topic could be beneficial in finding appropriate influenza 
vaccination strategy to increase the responsiveness in adults who are obese.  
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